Holen Sie sich die Stockscreener-App
1.43
5.93%
0.08
Handel nachbörslich:
1.40
-0.03
-2.10%
Schlusskurs vom Vortag:
$1.35
Offen:
$1.37
24-Stunden-Volumen:
17.13M
Relative Volume:
1.59
Marktkapitalisierung:
$912.36M
Einnahmen:
$29.48M
Nettoeinkommen (Verlust:
$-201.19M
KGV:
-4.4688
EPS:
-0.32
Netto-Cashflow:
$-216.50M
1W Leistung:
+2.88%
1M Leistung:
+8.33%
6M Leistung:
-48.75%
1J Leistung:
-68.71%
1-Tages-Spanne:
$1.34
$1.465
1-Wochen-Bereich:
$1.26
$1.465
52-Wochen-Spanne:
$1.09
$4.825
Geron Corp Stock (GERN) Company Profile
Firmenname
Geron Corp
Sektor
Branche
Telefon
(650) 473-7700
Adresse
919 EAST HILLSDALE BOULEVARD, FOSTER CITY, CA
Vergleichen Sie GERN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
GERN
Geron Corp
|
1.43 | 861.32M | 29.48M | -201.19M | -216.50M | -0.32 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.92 | 99.42B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.55 | 58.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.52 | 56.35B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
646.60 | 39.02B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
307.51 | 34.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Geron Corp Stock (GERN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-10 | Fortgesetzt | Goldman | Sell |
| 2025-05-08 | Herabstufung | Scotiabank | Sector Outperform → Sector Perform |
| 2025-02-27 | Herabstufung | B. Riley Securities | Buy → Neutral |
| 2025-02-26 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2024-11-05 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-10-16 | Eingeleitet | Scotiabank | Sector Outperform |
| 2024-09-09 | Eingeleitet | Leerink Partners | Outperform |
| 2024-04-30 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2024-04-29 | Eingeleitet | TD Cowen | Buy |
| 2024-03-15 | Bestätigt | Needham | Buy |
| 2023-09-12 | Hochstufung | Goldman | Neutral → Buy |
| 2023-03-28 | Eingeleitet | Goldman | Neutral |
| 2022-10-28 | Eingeleitet | Wedbush | Outperform |
| 2022-07-28 | Fortgesetzt | B. Riley Securities | Buy |
| 2021-11-02 | Eingeleitet | Robert W. Baird | Outperform |
| 2021-02-18 | Fortgesetzt | B. Riley Securities | Buy |
| 2020-08-03 | Eingeleitet | Stifel | Buy |
| 2019-11-19 | Fortgesetzt | B. Riley FBR | Buy |
| 2019-09-03 | Eingeleitet | H.C. Wainwright | Buy |
| 2019-08-15 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2019-04-09 | Hochstufung | Needham | Hold → Buy |
| 2019-01-31 | Hochstufung | B. Riley FBR | Neutral → Buy |
| 2018-10-02 | Herabstufung | B. Riley FBR | Buy → Neutral |
| 2018-07-05 | Eingeleitet | B. Riley FBR, Inc. | Buy |
| 2016-09-13 | Bestätigt | FBR & Co. | Outperform |
| 2016-09-13 | Bestätigt | FBR Capital | Outperform |
| 2015-12-07 | Bestätigt | Piper Jaffray | Overweight |
| 2015-04-21 | Eingeleitet | Oppenheimer | Outperform |
| 2014-06-12 | Hochstufung | MLV & Co | Hold → Buy |
| 2014-03-12 | Herabstufung | MLV & Co | Buy → Hold |
| 2013-12-10 | Bestätigt | MLV & Co | Buy |
| 2013-12-10 | Hochstufung | Needham | Hold → Buy |
| 2013-11-08 | Bestätigt | MLV & Co | Buy |
| 2013-10-16 | Eingeleitet | MLV & Co | Buy |
| 2012-08-30 | Eingeleitet | Stifel Nicolaus | Buy |
| 2012-06-28 | Eingeleitet | Needham | Hold |
Alle ansehen
Geron Corp Aktie (GERN) Neueste Nachrichten
Geron Corporation Surges: CEO Appointment and Q2 Triumph - StocksToTrade
Geron Corporation Breaks Below Key Support LevelQuarterly Portfolio Report & Fast Exit/Entry Strategy Plans - 선데이타임즈
Geron Second Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
Leerink Partnrs Issues Positive Estimate for Geron Earnings - Defense World
Visual trend scoring systems applied to Geron CorporationChart-Based Entry Confirmation for Beginners - Newser
Q1 Earnings Forecast for Geron Issued By Wedbush - Defense World
Geron Corporation (NASDAQ:GERN) Given Consensus Recommendation of “Moderate Buy” by Brokerages - Defense World
Geron Corporation Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - Yahoo Finance
Geron: I Think We've Seen This Movie Before (NASDAQ:GERN) - Seeking Alpha
A Quick Look at Today's Ratings for Geron(GERN.US), With a Forecast Between $4 to $5 - 富途牛牛
Geron Corporation (NASDAQ:GERN) Q2 2025 Earnings Call Transcript - Insider Monkey
Geron: Q2 Earnings Snapshot - Huron Daily Tribune
Geron Corp (GERN) Q2 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic Advancements - Investing.com Canada
Geron (GERN) Q2 Revenue Jumps 5,477% - sharewise.com
Semerjian to lead Geron - BioCentury
Geron reports Q2 EPS (2c), consensus (3c) - TipRanks
Geron Corporation Set to Release Q2 Financial Results, Eyes Market Reaction - StocksToTrade
Earnings call transcript: Geron surpasses Q2 2025 forecasts, stock rises By Investing.com - Investing.com South Africa
Earnings call transcript: Geron surpasses Q2 2025 forecasts, stock rises - Investing.com
Geron appoints Harout Semerjian as CEO - TipRanks
Geron (GERN) Reports Q2 Loss, Tops Revenue Estimates - Yahoo Finance
Geron Q2 2025 presentation: RYTELO sales climb 24%, stock jumps premarket - Investing.com
Geron earnings beat, revenue topped estimates By Investing.com - Investing.com Canada
Geron earnings beat, revenue topped estimates - Investing.com
Geron appoints Harout Semerjian as new CEO amid RYTELO expansion - Investing.com
Geron Corporation Reports Second Quarter 2025 Financial Results and Recent Business Highlights - Yahoo Finance
Geron Taps Former Novartis Hematology Leader as CEO: 30-Year Expert to Scale RYTELO Commercial Launch - Stock Titan
Universal Beteiligungs und Servicegesellschaft mbH Purchases New Holdings in Geron Corporation (NASDAQ:GERN) - Defense World
What is the dividend policy of Geron Corporation stockUnlock daily trading alerts for profits - Jammu Links News
What makes Geron Corporation stock price move sharplyExtraordinary earning power - Jammu Links News
Ball Corp Set to Report Q2 Earnings: What Lies Ahead for the Stock? - The Globe and Mail
Leerink Partners Reiterates a Buy Rating on Geron Corporation (GERN) With a $3 PT - Insider Monkey
Commercial Stage Biotech Geron Sets Q2 Earnings Release: Key Financial Updates Coming August 6 - Stock Titan
Geron Plans to Announce Second Quarter 2025 Financial Results on August 6, 2025 - Business Wire
How high can Geron Corporation stock price go in 2025Real Time Stock Signal - metal.it
What is the risk reward ratio of investing in Geron Corporation stockGet timely market insights for better trades - Jammu Links News
How volatile is Geron Corporation stock compared to the marketDynamic growth stocks - Jammu Links News
Geron (GERN.O) Surges 5.08%: What’s Driving the Intraday Rally? - AInvest
What analysts say about Geron Corporation stockOutstanding stock performance - jammulinksnews.com
Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)July 18, 2025 - BioSpace
Market Sentiment Around Loss-Making Geron Corporation (NASDAQ:GERN) - simplywall.st
Geron Corporation Stock Analysis and ForecastOutstanding capital returns - jammulinksnews.com
Geron Corporation (GERN) Plunges 3.88% to 2025 Low on Earnings Miss - AInvest
Commercial Stage Biotech Geron Expands Team with 342,000 Share Equity Package for Strategic New Hires - Stock Titan
Why Geron Corporation stock attracts strong analyst attentionTechnical Breakout List - Newser
Geron Presents Positive RYTELO Data for LR-MDS at ASCO & EHA, Highlights Efficacy, Myelofibrosis Program Progress - Insider Monkey
Geron Corporation (NASDAQ:GERN) Receives Average Recommendation of “Moderate Buy” from Analysts - Defense World
Geron (NASDAQ:GERN) Shares Gap Down – Here’s Why - Defense World
Cambridge Investment Research Advisors Inc. Cuts Stock Position in Geron Corporation (NASDAQ:GERN) - Defense World
Here’s Why Geron Corp. (NASDAQ:GERN) Crashed Today - MSN
Geron resumed with a Sell at Goldman Sachs - TipRanks
Finanzdaten der Geron Corp-Aktie (GERN)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):